These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 22401633

  • 1. Clinical validation of sublingual formulations of Immunoxel (Dzherelo) as an adjuvant immunotherapy in treatment of TB patients.
    Efremenko YV, Arjanova OV, Prihoda ND, Yurchenko LV, Sokolenko NI, Mospan IV, Pylypchuk VS, Rowe J, Jirathitikal V, Bourinbaiar AS, Kutsyna GA.
    Immunotherapy; 2012 Mar; 4(3):273-82. PubMed ID: 22401633
    [Abstract] [Full Text] [Related]

  • 2. Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.
    Batbold U, Butov DO, Kutsyna GA, Damdinpurev N, Grinishina EA, Mijiddorj O, Kovolev ME, Baasanjav K, Butova TS, Sandagdorj M, Batbold O, Tseveendorj A, Chunt E, Zaitzeva SI, Stepanenko HL, Makeeva NI, Mospan IV, Pylypchuk VS, Rowe JL, Nyasulu P, Jirathitikal V, Bain AI, Tarakanovskaya MG, Bourinbaiar AS.
    Immunotherapy; 2017 Jan; 9(1):13-24. PubMed ID: 27868466
    [Abstract] [Full Text] [Related]

  • 3. Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV.
    Butov DA, Efremenko YV, Prihoda ND, Yurchenko LI, Sokolenko NI, Arjanova OV, Stepanenko AL, Butova TS, Zaitzeva SS, Jirathitikal V, Bourinbaiar AS, Kutsyna GA.
    Immunotherapy; 2012 Jul; 4(7):687-95. PubMed ID: 22853755
    [Abstract] [Full Text] [Related]

  • 4. Adjunct oral immunotherapy in patients with re-treated, multidrug-resistant or HIV-coinfected TB.
    Arjanova OV, Prihoda ND, Yurchenko LV, Sokolenko NI, Frolov VM, Tarakanovskaya MG, Batdelger D, Jirathitikal V, Bourinbaiar AS.
    Immunotherapy; 2011 Feb; 3(2):181-91. PubMed ID: 21182457
    [Abstract] [Full Text] [Related]

  • 5. Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator Dzherelo.
    Zaitzeva SI, Matveeva SL, Gerasimova TG, Pashkov YN, Butov DA, Pylypchuk VS, Frolov VM, Kutsyna GA.
    Clin Microbiol Infect; 2009 Dec; 15(12):1154-62. PubMed ID: 19456829
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of efficacy of tuberculosis drugs with Immunoxel (Dzherelo) in HIV-infected patients with active pulmonary tuberculosis.
    Arjanova OV, Prihoda ND, Yurchenko LV, Sokolenko NI, Vihrova LA, Pylypchuk VS, Frolov VM, Kutsyna GA.
    Immunotherapy; 2009 Jul; 1(4):549-56. PubMed ID: 20635986
    [Abstract] [Full Text] [Related]

  • 7. Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin.
    Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Frolov VM, Kutsyna GA.
    Cytokine; 2008 Dec; 44(3):392-6. PubMed ID: 19027322
    [Abstract] [Full Text] [Related]

  • 8. Dzherelo (Immunoxel) as adjunctive therapy to standard antituberculosis treatment in patients with pulmonary tuberculosis: a systematic review and meta-analysis of clinical trials.
    Kitenge M, Phiri B, Pheeha SM, Ogunrombi M, Nyasulu PS.
    Syst Rev; 2021 May 26; 10(1):157. PubMed ID: 34039420
    [Abstract] [Full Text] [Related]

  • 9. Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?
    Dubrovina I, Miskinis K, Lyepshina S, Yann Y, Hoffmann H, Zaleskis R, Nunn P, Zignol M.
    Int J Tuberc Lung Dis; 2008 Jul 26; 12(7):756-62. PubMed ID: 18544200
    [Abstract] [Full Text] [Related]

  • 10. Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS.
    Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Masyuk LA, Kutsyna GA.
    Int Immunopharmacol; 2008 Jun 26; 8(6):845-51. PubMed ID: 18442788
    [Abstract] [Full Text] [Related]

  • 11. Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7).
    Butov DA, Efremenko YV, Prihoda ND, Zaitzeva SI, Yurchenko LV, Sokolenko NI, Butova TS, Stepanenko AL, Kutsyna GA, Jirathitikal V, Bourinbaiar AS.
    Immunotherapy; 2013 Oct 26; 5(10):1047-54. PubMed ID: 24088075
    [Abstract] [Full Text] [Related]

  • 12. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct 26; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 26; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 14. Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients.
    Nikolaeva LG, Maystat TV, Masyuk LA, Pylypchuk VS, Volyanskii YL, Kutsyna GA.
    Drug Des Devel Ther; 2009 Feb 06; 2():87-93. PubMed ID: 19920896
    [Abstract] [Full Text] [Related]

  • 15. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
    Palacios E, Franke M, Muñoz M, Hurtado R, Dallman R, Chalco K, Guerra D, Mestanza L, Llaro K, Bonilla C, Sebastian J, Bayona J, Lygizos M, Anger H, Shin S.
    Int J Tuberc Lung Dis; 2012 Feb 06; 16(3):348-54. PubMed ID: 22640448
    [Abstract] [Full Text] [Related]

  • 16. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S.
    Int J Tuberc Lung Dis; 2013 Apr 06; 17(4):526-31. PubMed ID: 23485387
    [Abstract] [Full Text] [Related]

  • 17. Determinants of drug-resistant tuberculosis: analysis of 11 countries.
    Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE, Smith I, Suarez P, Antunes ML, George AG, Martin-Casabona N, Simelane P, Weyer K, Binkin N, Raviglione MC.
    Int J Tuberc Lung Dis; 2001 Oct 06; 5(10):887-93. PubMed ID: 11605880
    [Abstract] [Full Text] [Related]

  • 18. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS.
    Int J Tuberc Lung Dis; 2012 Dec 06; 16(12):1588-93. PubMed ID: 23032215
    [Abstract] [Full Text] [Related]

  • 19. Multidrug-resistant TB and HIV in Thailand: overlapping, but not independently associated, risk factors.
    Akksilp S, Wattanaamornkiat W, Kittikraisak W, Nateniyom S, Rienthong S, Sirinak C, Ngamlert K, Mankatittham W, Sattayawuthipong W, Sumnapun S, Yamada N, Monkongdee P, Anuwatnonthakate A, Burapat C, Wells CD, Tappero JW, Varma JK.
    Southeast Asian J Trop Med Public Health; 2009 Sep 06; 40(5):1000-14. PubMed ID: 19842383
    [Abstract] [Full Text] [Related]

  • 20. Patterns of anti-tuberculosis drug resistance among HIV-infected patients in Maputo, Mozambique, 2002-2003.
    Nunes EA, De Capitani EM, Coelho E, Joaquim OA, Figueiredo IR, Cossa AM, Panunto AC, Carvalho-Ramos M.
    Int J Tuberc Lung Dis; 2005 May 06; 9(5):494-500. PubMed ID: 15875919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.